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Abstract 
Injectable bone fillers represent an attractive strategy for the treatment of bone defects. These 
injectable materials should be biocompatible, capable of supporting cell growth and possibly 
able to exert antibacterial effects. 
In this work, nanocomposite microbeads based on alginate, chitlac, hydroxyapatite and silver 
nanoparticles were prepared and characterized. The dried microbeads displayed a rapid 
swelling in contact with simulated body fluid and maintained their integrity for more than 30 
days. The evaluation of silver leakage from the microbeads showed that the antibacterial 
metal is slowly released in saline solution, with less than 6% of silver released after 1 week. 
Antibacterial tests proved that the microbeads displayed bactericidal effects toward S. aureus, 
P. aeruginosa and S. epidermidis and were also able to damage pre-formed bacterial biofilms. 
On the other hand, the microbeads did not exert any cytotoxic effect towards osteoblast-like 
cells.  
After characterization of the bioactive microbeads, a possible means to embed them in a fluid 
medium was explored in order to obtain an injectable paste. Upon suspension of the particles 
in alginate solution or alginate/hyaluronic acid mixtures, a homogenous and time-stable paste 
was obtained.  Mechanical tests enabled to quantify the extrusion forces from surgical 
syringes, pointing out the proper injectability of the material. This novel antibacterial bone-
filler appears as a promising material for the treatment of bone defects, in particular when 
possible infections could compromise the bone-healing process.  
 
Keywords: bone healing; injectable fillers; polysaccharides; antibacterial properties; silver 
nanoparticles 
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1 Introduction 
Injectable bone fillers represent an attractive strategy for the treatment of bone defects caused 
by traumatic injuries, cysts and pathologies characterized by an altered balance between bone 
tissue deposition and resorption (Lewis 2011; Oliveira et al. 2008; Page et al. 2013). These 
materials can be employed when these defects are small and not treatable with bone auto or 
allo-grafts, such as in case of scarcity of the donors or in immunocompromised patients 
(Mauffrey et al. 2015). 
Novel injectable materials used as bone fillers should be biocompatible, support cell growth 
and possibly exert antibacterial effects in order to prevent infections (Kneser et al. 2006; 
Page et al. 2013). Moreover, upon injection, the material should tightly fit the defect cavity 
and remain in situ for the time required to form the new bone tissue (Ghanaati et al. 2011; 
Kneser et al. 2006). 
Bone filler materials can be prepared using various components, like synthetic or natural 
polymers and bioceramic compounds (Alves Cardoso et al. 2014; Bongio et al. 2015; 
Nejadnik et al. 2014; Page et al. 2013; Sohrabi et al. 2014; Tadier et al. 2014). Among the 
bioceramic, hydroxyapatite (HAp) or β-tricalcium phosphate (β-TCP) have been widely 
employed owing to their osteoconductive properties (Bongio et al. 2015; Kneser et al. 2006). 
Although these materials are effective in supporting bone tissue growth, the risk of 
periprosthetic infections remains a major threaten, especially in body districts with particular 
exposure to bacteria (e.g. mouth environment) (Norowski and Bumgardner 2009). These 
infections are a sever complication that can be as high as 5 % of the total number of implants 
and, in the case of bone implants, can lead to tissue damage, implant failure or mortality 
(Campoccia et al. 2006; Gristina 1987). Despite the local delivery of antibiotics loaded on 
implantable biomaterials can be achieved (Wei et al. 2012), the development of antibiotic 
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resistances remains a severe problem (Campoccia et al. 2010; Campoccia et al. 2006). To 
overcome this issue, the employment of alternative wide spectrum antibacterial agents is 
sought (Lara et al. 2011; Morones-Ramirez et al. 2013); among them, silver ions and 
nanoparticles (nAg) have been successfully employed for the manufacturing of antibacterial 
bone implants (Goudouri et al. 2014; Marsich et al. 2013; Reithofer et al. 2014; Stojkovska et 
al. 2014; Taglietti et al. 2014; Travan et al. 2009). Recently, a lactose-modified chitosan 
(Chitlac) has been employed for the synthesis of nAg and the resulting system (Chitlac-nAg) 
was used to prepare antibacterial coatings (Marsich et al. 2013; Nganga et al. 2013; Travan et 
al. 2012). Moreover, the miscibility of Chitlac with alginate was previously exploited to 
prepare bioactive hydrogels in the form of scaffolds and microbeads, exploiting the gel-
forming properties of alginate (Marsich et al. 2008; Marsich et al. 2013; Travan et al. 2009). 
Given these premises, the scope of this work was to prepare and characterize microbeads 
based on alginate/Chitlac-nAg and HAp for bone tissue regeneration. Moreover, this study 
aimed at obtaining a preliminary evaluation of the possibility to obtain an injectable paste by 
embedding the microbeads in fluid medium, thus combining the osteoconductive and the 
antibacterial properties of the components in an injectable bone-filler device.  
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2 Materials and methods 
2.1 Materials 
Sodium alginate samples isolated from Laminaria hyperborea were provided by FMC 
BioPolymer AS (Norway). The (viscosity average) relative molecular mass (“molecular 
weight”, MW) was found to be approximately 120 000 as determined by capillary 
viscosimetry according to Vold et al (Vold et al. 2006). The composition of the alginate 
sample was determined by means of 
1
H-NMR and resulted to be FG = 0.68, FM = 1 - FG = 
0.32, FGG = 0.57, FGM+MG = 0.22, FMM = 0.21, NG>1 = 14, where FG and FM denote the mole 
fraction of alginate monomers as α-L-guluronic acid (G) and β-D-mannuronic acid (M), 
respectively, FGG indicates the fraction of G dimers, FMM indicates the fraction of M dimers 
and FGM+MG indicates the fraction of any mixed sequence of G and M (irrespective of 
sequence). NG>1 is the number-average number (  ) of G monomer in homopolymeric 
sequences having    ≥ 2. Hyaluronic Acid (HA150, MW 1 500 000) was provided by FMC 
BioPolymer AS (Norway). Highly deacetylated chitosan (residual acetylation degree 
approximately 16 % as determined by means of 
1
H-NMR), was purchased from Sigma-
Aldrich (Chemical Co. USA). The relative MW of chitosan, determined by intrinsic viscosity 
measurements, was found to be around 690 000 (Donati et al. 2005). Chitlac (lactose-
modified chitosan, CAS registry number 85941-43-1) was prepared according to the 
procedure reported elsewhere starting from highly deacetylated chitosan (Donati et al. 2005; 
Yalpani and Hall 1984). The composition of Chitlac was determined by means of 
1
H-NMR 
and resulted to be: glucosamine residue 27 %, N-acetylglucosamine 18 % and 2-(lactit-1-yl)-
glucosamine 55 %. The calculated relative MW of Chitlac is around 1.5   106. Silver nitrate 
(AgNO3), ascorbic acid (C6H8O6), LDH (lactate dehydrogenase)-based TOX-7 kit, phosphate 
buffered saline (PBS), Luria–Bertani (LB) broth, LB Agar and Brain Heart Infusion (BHI) 
were purchased from Sigma-Aldrich (Chemical Co. USA). Trypsin/EDTA solutions, Fetal 
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Bovine Serum (FBS), penicillin streptomycin 100X, l-glutamine 100X, Dulbecco’s modified 
Eagle’s medium (DMEM) were purchased from EuroClone (Milan, Italy). FilmTracer™ 
FM
®
 1-43 Green Biofilm Cell Stain and FilmTracer Live/Dead biofilm viability kit were 
purchased from Invitrogen (U.S.A.). All other chemicals were of analytical grade. 
2.2 Synthesis of Chitlac–silver nanoparticles (Chitlac-nAg) 
Silver nanoparticles (nAg) were obtained by reducing silver ions with ascorbic acid in Chitlac 
solution. Freeze-dried Chitlac was dissolved in deionized water to obtain a 4 g/L solution. 
Silver nitrate (AgNO3) was added to Chitlac at final concentration of 1 mM; then, ascorbic 
acid was added at final concentration of 0.5 mM. The solution was kept for 4 hours at room 
temperature in darkness and then stored at 4 °C. 
2.3 Preparation of Microbeads 
Microbeads were prepared following a well-defined protocol previously reported by some of 
the authors (Marsich et al. 2008; Travan et al. 2009). Two types of microbeads have been 
prepared and tested: microbeads with silver nanoparticles (nAg-MB) and without silver 
nanoparticles (MB); both microbeads contained alginate, Chitlac and HAp. The MB have 
been prepared from an aqueous mixture composed by alginate (final concentration, 20 g/L), 
HAp (final concentration, 3% w/V) and Chitlac (final concentration, 2% g/L). In order to 
achieve a good miscibility of alginate and Chitlac, NaCl (final concentration 0.15 M) and 
HEPES (final concentration 0.01 M, pH 7.4) have been added to the mixture. The nAg-MB 
were prepared with the same procedure of the MB, employing Chitlac-nAg instead of 
Chitlac, as detailed in paragraph 2.2, at the final concentration of 2g/L. 
MB and nAg-MB were obtained by dripping the mixed polymeric solutions into a gelling 
solution (aqueous 0.05 M CaCl2). The droplet size was controlled by use of a high voltage 
electrostatic bead generator (7.5 kV, 162 mL/h, steel needle with 0.7 mm outer diameter, 1 
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cm distance from the needle to the gelling solution) according to a procedure previously 
described (Travan et al. 2009). The gel microbeads obtained were stirred for 30 min in the 
gelling solution and washed three times in deionized water. 
Then, in order to obtain a material that could be easily handled and sterilized, microbeads 
were dried under air flux. Microbeads were sterilized for 1 h, under UV irradiation, before the 
use in the biological tests. 
2.4 Evaluation of total silver content and of silver release 
The total amount of silver in the nAg-MB and released from nAg-MB, soaked in saline or in 
deionized water, was determined by Inductively Coupled Plasma - Optical Emission 
Spectroscopy (ICP-OES) using an Optima 8000 ICP-OES Spectrometer (PerkinElmer, USA). 
The analysis were conducted using a calibration curve obtained by dilution (range: 0–10 
mg/L) of a silver standard solution (10015 µg/mL) for ICP-OES analyses (Sigma-Aldrich, 
USA). The limit of detection (LOD) at the operative wavelength of 328.068 was 0.016 mg/L. 
The precision of the measurements as relative standard deviation for the analysis was always 
less than 5%. 
The total amount of silver in the nAg-MB (ng Ag/mg beads) was measured upon treatment 
with concentrated H2SO4 and solubilization with concentrated HNO3. About 9 mg of 
microbeads were degraded in 60 µL of H2SO4, than the volume was adjusted to 1.2 mL with 
HNO3 to ensure the solubilization of silver precipitates. At the end, the volume was adjusted 
to 5 mL with deionized water. The average amount of silver was calculated as the mean of 
silver quantity measured in three samples. 
For the quantification of silver released from the nAg-MB, about 50 mg of sample were 
incubated, in agitation, with a volume ratio solution/microbeads of 10. Every 24 h, 
supernatants from the microbeads suspensions were collected and analyzed and fresh solution 
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was added to the microbeads. After the last solution change, the microbeads were washed 
with filtered deionized water to recover all the precipitated silver salts; the solution was then 
filtered (0.22 µm) and collected. 
 
 
2.5 Scanning Electron Microscopy 
The air-dried microbeads were mounted on aluminum stubs covered with two-sides 
conductive carbon adhesive tape. Next, the samples were sputtered with gold (Sputter Coater 
K550X, Emitech, Quorum Technologies Ltd, UK) and immediately analyzed by means of a 
scanning electron microscope (Quanta250 SEM, FEI, Oregon, USA) operated in secondary 
electron detection mode. The working distance was adjusted in order to obtain the suitable 
magnification; the accelerating voltage was set to 30kV. 
2.6 Microbeads swelling and stability 
The swelling and the stability of microbeads were measured as the average diameter variation 
upon immersion in Simulated Body Fluid (SBF) prepared as reported by Kokubo et al. 
(Kokubo et al. 1990). Each test was performed in triplicate on a known number of beads (70-
100 range). The diameter variation of the microbeads was measured by collecting the images 
with a Pentax K100D camera mounted on an optical microscope (Olympus CK 2, Tokyo, 
Japan); the diameter of beads population was measured by means of an image analysis 
software (ImageJ, U.S.A.). The microbeads were analyzed every two days from the 
beginning of the swelling experiment. From day 15, diameters were recorded every week. 
The soaking solution was changed every two days.  
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2.7 Preparation of the injectable bone-filler (paste) 
The microbeads (30%w/w) were dispersed in the polysaccharide solution and transferred into 
syringes (1 mL, nozzle diameter 2 mm, Chemil, Italia). The solution was composed either by 
alginate (4%w/V) or by alginate (3%w/V) plus hyaluronic acid (1%w/V).  
2.8 Injectability tests  
The injectability tests were performed by applying an axial compression load to the syringe 
plunger by means of a Universal Testing Machine (Mecmesin MultiTest 2.5-I) coupled with a 
100 N load cell. A compression rate of 15 mm/min was applied along 50 mm of plunger 
displacement, recording the load applied. For each formulation, five replicates have been 
used; the average load in the plateau region was measured and standard deviations calculated. 
2.9 Antibacterial tests 
The antibacterial activity of nAg-MB was evaluated using strains of Staphylococcus 
epidermidis (ATCC
®
 12228
TM
), Staphylococcus aureus (ATCC
®
 25923
TM
) and Pseudomonas 
aeruginosa (ATCC
®
 27853
TM
), and using MB as a control. 
2.10 Growth inhibition assay 
Bacterial suspensions were prepared by adding 20 µL of bacteria, preserved in glycerol, to 5 
mL of LB broth. The obtained suspensions were incubated overnight at 37 °C. After 24 h, 
500 µL of bacterial suspension was diluted in 10 mL of broth and grown up for 90 min at 37 
°C in order to restore an exponential growth phase. Bacterial concentration was measured by 
means of optical density (OD) at 600 nm. The bacterial suspension was then diluted in 10 % 
(v/v) LB broth in PBS to obtain a final concentration of 10
6
 bacteria/mL. 1 mL of bacterial 
suspension was added to each microbeads sample (50 mg). S. aureus and P. aeruginosa were 
incubated at 37 °C for 4 h, S. epidermidis for 24 h. Tests were carried out in shaking 
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condition (140 r.p.m.). At the end of incubation, bacterial suspension was collected and 
serially diluted in PBS (from 10
-1
 to 10
-5
) and 25 µL of each suspension were plated on LB 
agar. After overnight incubation at 37 °C, the colony forming units (CFU) were counted. 
Outcomes were compared with a suspension of bacteria grown in liquid medium as control. 
Data are reported as the mean of three independent determinations. 
2.11 Biofilm formation 
Bacterial suspensions of S. aureus and P. aeruginosa were prepared by adding 20 µL of 
bacteria, preserved in glycerol, to 5 mL of BHI broth enriched with 3% w/v sucrose. The 
obtained suspensions were incubated overnight at 37 °C. After 24 h, bacteria were diluted 
1:100 in the same broth and plated (200 µL/well) into 96-well plates. For confocal laser 
scanning microscopy analyses, bacteria were plated on sterile 13 mm tissue culture coverslips 
(Sarstedt, USA) placed on the bottom of culture plate wells. Plates were incubated at 37 °C 
for 24 h allowing biofilm formation. After 24 h, broth was removed and formed biofilm was 
carefully rinsed with 100 µL of sterile PBS in order to remove non-adherent cells. 200 µL of 
10% LB in PBS were then added to each well and microbeads were deposited on the bacterial 
layer. Biofilms treated with microbeads were then incubated at 37 °C for 
4 h; then the viability of the biomass was assessed, as described in the following paragraph.  
2.12 Viable biomass assessment 
The viable biomass assessment was performed staining the biofilm with the FilmTracer™ 
FM
®
 1-43 Green Biofilm Cell Stain. The staining solution was prepared by diluting 10 μL of 
stock solution into 990 μL of DMSO, followed by diluting 100 μL into 0.9 mL of filter-
sterilized water. After the biofilm incubation period, microbeads and medium were gently 
removed from the plates and each well was carefully rinsed with filter-sterilized deionized 
water, in order to remove non-adherent cells. 20 µL of staining solution were placed into each 
  
This article is protected by copyright. All rights reserved. 
well and the plates were incubated for 30 minutes under lightproof conditions at room 
temperature. After the incubation period, each well was washed with filter-sterilized 
deionized water; then 80 µL of deionized water were added and the fluorescence was read 
with a spectrofluorimeter (λexc 485 nm, λem 520 nm, FLUOstar Omega, BMG LABTECH, 
Germany). Outcomes were expressed as fluorescence units. 
2.13 Confocal laser scanning microscopy 
Confocal laser scanning microscopy (CLSM) studies were addressed at detecting 
viability/death of bacteria grown in the biofilm community. FilmTracer Live/Dead biofilm 
viability kit was used. Dead cells were stained by propidium iodide, (red fluorescence: λexc 
514 nm; λem 590 nm) whereas live cells by SYTO
®
 9 (green fluorescence: λexc 488 nm; λem 
515 nm). Staining was performed on biofilms grown on coverslips as described above, 
according to the manufacture’s protocol. Images were acquired on a Nikon Eclipse C1si 
confocal laser-scanning microscope with a Nikon Plan Fluor 20  as objective. Resulting 
stacks of images were analyzed using ImageJ software. 
2.14 Osteoblast cell culture 
Osteosarcoma MG-63 (ATCC
®
 CRL-1427) human cell line was cultured in Dulbecco’s 
Modified Eagle’s Medium high glucose (Euro-Clone, Italy), 10 % heat-inactivated fetal 
bovine serum (Sigma Aldrich, Chemical Co. USA), 100 U/mL penicillin, 100 µg/mL-1 
streptomycin and 2 mM  
L-glutamine in a humidified atmosphere of 5 % CO2 at 37 °C. Cells were passaged at 80-90% 
of confluence and medium was changed every 2 days. For the experimental procedures, cells 
at the fourth/fifth passage were used. 
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2.15 Cytotoxicity tests 
In vitro cytotoxicity of nAg-MB was evaluated by using lactate dehydrogenase cytotoxicity 
assay (SIGMA TOX-7LDH assay), and using MB as a control. UV-sterilized microbeads 
were placed in Dulbecco’s modified Eagle’s medium, inactivated fetal bovine serum 10 %, 
penicillin 100 U/mL, streptomycin 100 µg/mL and L-glutamine 2 mM for 24 h. After 24 h of 
incubation, the cytotoxicity test was performed by direct contact of the cells with the swollen 
microbeads (20 mg per well). Cells were seeded into 24-well plates (30 000 cells per well) 
and incubated 24 hours before the cytotoxicity test. After the first day, the medium was 
changed and the cells were incubated for 24 and 72 hours with microbeads. After 24 and 72 
hours, the medium was collected and the test was performed following the manufacturer’s 
protocol. The experiments were performed in triplicate. The absorbance was measured at 490 
nm and 690 nm, with a Tecan Nano Quant Infinite M200 Pro plate reader. The cytotoxicity 
was calculated using the following equation: 
                  
                                          
                                        
 
normalizing the values for the total LDH of the control cell lysate. Polystyrene (PS) was used 
as a negative control; zinc embedded polyurethane (PU/Zn) membrane was used as positive 
control. 
Moreover, at 72 hours, before collection of the medium, images of cells were taken with a 
Pentax K100D camera mounted on an optical microscope (Olympus CK 2, Tokyo, Japan). 
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2.16 Statistical analyses 
Statistical analyses were performed by means of SPSS Statistics 21 (IBM SPSS Statistics; 
SPSS Inc., Chicago, IL, USA). Data of the bacterial growth inhibition satisfied both the 
normality (Kolmogorov–Smirnov test) and equality variance (Levene test) assumptions 
allowing therefore to use a t test. Both the data for the intensity of fluorescence of the biofilm 
and the LDH release were not normally distributed according to Levene’s test. Kruskal-
Wallis and by Mann–Whitney non-parametric tests were therefore used. Statistical 
significance was pre-set at α=0.05. 
 
3 Results and discussion 
3.1 Microbeads preparation 
This work aimed at the preparation and the characterization of nanocomposite microbeads to 
be used as bioactive bone fillers. Microbeads based on the mixture of the selected 
polysaccharides were prepared by exploiting the gel-forming properties of alginate: the 
hydrogel beads were prepared dropping the aqueous mixtures of the biopolymers into an 
aqueous solution of CaCl2. In order to control the size of the beads, an electrostatic generator 
was used (Figure 1A). This technique is widely used in literature for the preparation of 
biocompatible polysaccharide microbeads (Morch et al. 2006; Travan et al. 2009) and can be 
used for the encapsulation of cells within alginate gel matrices (Marsich et al. 2008). 
To further implement the bioactivity of the beads, the lactose-modified chitosan (Chitlac) was 
added to the polymer mixture. Previous studies by some of the authors have demonstrated 
that Chitlac possesses bioactive properties: in Marsich et al. (Marsich et al. 2008) and in 
Donati et al. (Donati et al. 2005) it was reported that Chitlac is able to stimulate the growth 
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and the proliferation of chondrocytes and the production of chondro-specific 
glycosaminoglycans (GAGs) and collagen. Chitlac has also been used for the preparation of 
bioactive coatings for methacrylic thermosets (Travan et al. 2012) and alginate scaffolds 
(Marsich et al. 2013), showing bioactive properties in terms of increased osteoblasts 
proliferation, alkaline phosphatase activity and bone-implant contact in the case of chitlac-
coated thermosets (Marsich et al. 2013). 
Moreover, to confer antibacterial properties to the materials, silver nanoparticles have been in 
situ synthesized within Chitlac solutions before being added to alginate solutions. As reported 
by Travan et al. (Travan et al. 2009), silver nanoparticles synthesized in Chitlac display high 
stability and homogeneous dimensions and are able to exert antibacterial effects without 
being toxic towards eukaryotic cells. 
In the present study, the method adopted for the preparation of the microbeads, enabled to 
obtain hydrogel microbeads with a narrow size distribution and an average size of (990 ± 60) 
µm, as determined by optical microscopy imaging; Figure 1B-D point out that the size 
distribution was similar for microbeads with (nAg-MB) or without (MB) silver nanoparticles. 
 
The concentration of alginate and HAp were optimized in order to reach a compromise 
between the maximization of the concentration of the osteoconductive component and the 
formation of a stable alginate mesh in the microbeads (Turco et al. 2009). 
In order to obtain the dried composite powder required for the sterilization of the material and 
for the preparation of the injectable filler, the hydrogel beads were dehydrated by air flux, 
thus obtaining the dried composite particles. The dried particles were analyzed by SEM in 
order to evaluate size and morphology; as expected, drying the hydrogel microbeads led to a 
significant reduction of their dimensions (MB: 250 ± 40 µm; nAg-MB: 270 ± 40 µm). These 
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values are in the range commonly employed for the preparation of composite bone fillers 
based on HAp or β-TCP (Suzuki et al. 2014; Tadier et al. 2014). 
The SEM analysis enabled also to highlight how the bead surfaces are roughened by the 
presence of HAp crystals that protrude from both MB and nAg-MB particles (Figure 2B and 
2D). 
 
3.2 Swelling and stability 
The swelling behavior and stability were investigated by incubating the dried microbeads in 
Simulated Body Fluid (SBF) at 37 °C and replacing it at fixed days. SBF is widely used for 
the evaluation of the stability and of the apatite-forming properties of biomaterials for bone 
tissue regeneration (Díez-Pascual and Díez-Vicente 2015; Gervaso et al. 2016; Tan et al. 
2010; Turco et al. 2009). In this work, the stability evaluation was performed without the use 
of degradation enzymes since it is known that there are not specific enzymes in mammalians 
for the degradation of alginate (Guarino et al. 2015; Lee and Mooney 2012). Moreover, it has 
been demonstrated that the enzyme lysozyme has only a minor effect on chitosan, and that 
this effect becomes even smaller when chitosan is functionalized with lactose (Diolosá et al. 
2014). 
The size variation of the microbeads soaked in SBF over time is reported in Figure 3A: the 
data show how the microbeads underwent a considerable swelling leading to an increase of 
their dimension, owing to the presence of the hydrophilic polysaccharides. The microbeads 
rapidly (approximately 2 days) reached a swelling equilibrium, with an increase of diameter 
and of volume which was respectively 3.5-fold and 43-fold compared to the initial values. 
The swelling rate of MB and  
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nAg-MB was similar (Figure 3A) and did not affect the morphology of the microbeads  
(Figure 3 B and C).  
The experiment went on for 31 days, pointing out the excellent morphological stability of the 
microbeads, which did not show any significant degradation in physiological-like conditions. 
These data confirm the stability of biomaterials based on alginate hydrogels containing HAp, 
as already observed in the case of tridimensional scaffolds for bone tissue regeneration 
(Porrelli et al. 2015; Turco et al. 2009). 
Considering the final application (the preparation of an injectable system), the swelling and 
degradation behavior found represent a positive feature of the material. This feature enables 
the injectable filler to adapt to the bone defect and remain firmly in situ for several weeks, 
thus assisting the natural bone regrowth process. In fact, the prolonged stability of an 
injectable material is a key factor in the regeneration of the bone tissue (Ghanaati et al. 2011; 
Grynpas et al. 2002; von Doernberg et al. 2006), as new bone tissue formation requires 
several weeks (Urist 1965). 
3.3 Silver release from nAg-MB 
The amount of silver contained in the nAg-MB has been quantified by means of ICP-OES; 
the analysis revealed that 1 mg of microbeads contains (0.978 ± 0.146) μg of silver (data 
averaged on three samples). 
The silver release from the nAg-MB has been measured soaking the microbeads in deionized 
water and in saline solution (NaCl 0.15 M); in order to put the particles in contact with 
abundant liquid, the ratio between the volume of water/solution and the volume of 
microbeads was 10. To mimic real conditions, the solutions were changed every 24 h and the 
microbeads were subjected to mechanical agitation. The silver released from the microbeads 
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over time was reported both as the percentage of silver released each day (Figure 4A) or as 
the cumulative release (Figure 4B).  
The data point out that for both water and saline solution the silver released upon daily shifts 
is typically lower than 1%, while after 7 days the cumulative silver release was (5.69 ± 
0.95)% in saline solution and (0.36 ± 0.12)% in water. The higher release in saline is 
explainable considering that the presence of ions can accelerate the swelling of the polymer 
mesh, which increases the exposure of silver nanoparticles to the environment. Moreover, it 
is known that the dissolution of silver nanoparticles and the release of silver ions are 
influenced by ionic strength and the chloride concentration of the solution (Chambers et al. 
2014). However, in both cases, the silver release was very low since only 0.56 ng per mg of 
bead has been released after 7 days, thus proving the structural stability of the polymer mesh. 
Comparing the results of silver release and swelling behavior of the microbeads, one could 
expect a burst release of silver in a timeframe compatible with the swelling of the microbeads 
(see Figure 3); however, the results did not point out such behavior. The absence of a burst 
release can be explained considering that in this system the silver nanoparticles are 
chemically stabilized by Chitlac, which in turn is closely embedded in the alginate matrix of 
microbeads.  
The amount of silver released from nAg-MB is higher if compared to that of alginate/Chitlac-
nAg hydrogels devoid of HAp reported by Travan et al. (Travan et al. 2009); this result can 
be explained by the fact that the introduction of HAp can affect the formation of alginate egg-
box, thus reducing the stability of the material. However, the silver released from nAg-MB is 
lower than that reported for tridimensional alginate/HAp scaffolds coated with Chitlac-nAg 
(Marsich et al. 2013) thus pointing out that silver release can be tuned by employing different 
methods of incorporation in the biomaterial.  
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Overall, the profile of the silver released from the nAg-MB appears particularly appealing for 
bone tissue engineering applications, since it ensures a long-term stability of the antibacterial 
agent, thus avoiding a burst release of metal ions that could potentially be toxic for the cells 
of the surrounding tissues. Moreover, the slow release of silver contributes to prolong the 
antibacterial effect of the nanoparticles, which is also related to the direct contact with 
bacterial cells (Travan et al. 2009). 
 
3.4 Antibacterial properties 
The antibacterial properties of nAg-MB were assessed in terms of inhibition of bacterial 
growth and eradication of biofilms produced by three bacterial strains: S. aureus, P. 
aeruginosa and  
S. epidermidis. These strains have been selected because of their role in bone-related 
infections and their antibiotic-resistance mechanisms (Gottenbos et al. 2000; Kilgus et al. 
2002; Moran et al. 2010; Parvizi et al. 2009; Toms et al. 2006). The assays have been 
performed incubating the microbeads (nAg-MB or MB) in direct contact with bacteria for 
chosen times. 
For S. aureus and P. aeruginosa, the growth inhibition assay was performed by incubating 
the bacterial suspension with the dried microbeads for 4 hours, after which the colony 
forming units (CFU) were measured; in both cases, the nAg-MB induced a significant 
decrease of the CFU, whose number was reduced by several orders of magnitude (Figure 5A-
B). 
In the case of S. epidermidis, no antibacterial effect was detected after 4 hours of incubation 
(data not shown). For this reason, the incubation was prolonged to 24 hours, which revealed 
to be a sufficient time for the nAg-MB to exert a bactericidal effect; in fact, a decrease of 
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more than 4 orders of magnitude was found in the case of the silver-containing particles 
(Figure 5C). The observed higher resistance of S. epidermidis was in line with the results 
reported in a previous work by Marsich et al. (Marsich et al. 2013). 
 
Once the effectiveness of the silver-containing particles in inhibiting bacterial growth had 
been verified, a further test has been carried out to evaluate their effect towards pre-formed 
biofilms. This assay was performed on S. aureus and P. aeruginosa strains, since S. 
epidermidis does not produce a self-protecting biofilm. Bacterial biofilms were put in contact 
with the microbeads for four hours and the bacteria viability was quantified using the Green 
Biofilm Cell Stain assay, which exploits the fluorescence intensity of the biomass as an 
indicator of viable bacteria within the biofilm. The results are reported in Figure 6. In the case 
of S. aureus, the nAg-MB displayed a strong anti-biofilm activity, since a 69% decrease of 
the fluorescence intensity was measured with respect to the control. In the case of P. 
aeruginosa the nAg-MB determined a 26% reduction of the biofilm fluorescence intensity; 
this milder effect could be ascribed to the high content of alginate in the P. aeruginosa 
biofilm, which represents a physical barrier towards antibacterial agents (Leid et al. 2005). 
 
The viability of bacteria within biofilms was also evaluated by the Live/Dead assay, which, 
by means of a fluorescence microscope, enables to distinguish between viable cells (green) 
and dead cells (orange-red); figure 7 collects the images of the biofilms after 4 hours of 
treatment with the particles, compared to untreated (control) biofilms. 
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In the case of S. aureus, the images clearly show the abundance of viable bacteria (green) for 
untreated (Figure 7A) and MB-treated biofilms (Figure 7B); at variance, the treatment with 
nAg-MB causes a clear inactivation of bacterial cells, appearing as red particles (Figure 7C). 
In the case of P. aeruginosa, the antibacterial effect of the nAg-MB can be inferred by the 
abundance of orange/red biomass (Figure 7G), at variance with control (Figure 7E) and MB-
treated bacteria (Figure 7F). Thus, the Live/Dead results are in line with the results of the 
Green Biofilm Cell Stain assay, both pointing out the antibacterial effect of nAg-MB on pre-
formed biofilms.  
Overall, the assays performed confirm the antibacterial properties of nAg-MB, in 
concordance with the data previously reported for alginate-based hydrogels (Travan et al. 
2009) or scaffolds (Marsich et al. 2013) enriched with Chitlac-nAg.  
 
3.5 Cytotoxicity and viability 
After studying the antibacterial activity of the microbeads, their effect towards eukaryotic 
cells was evaluated by the lactate dehydrogenase (LDH) assay, which enables to quantify the 
release of the LDH enzyme due to cellular damage; the assay has been carried out by putting 
an osteoblasts cell line (MG63) in direct contact the cells with microbeads for 24 and 72 
hours (accordingly to the ISO 10993−5 standard(1999)). Figure 8 shows the results of this 
cytotoxicity study as well as a qualitative evaluation of the morphology of the cells in contact 
with the materials. 
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The results of Figure 8A pointed out that both MB and nAg-MB particles were associated 
with low values (<15%) of LDH release, which remained significantly lower than the positive 
(cytotoxic) control (polyurethane/zinc). These quantitative data were confirmed by the 
qualitative investigation of cell morphology (Figure 8B), which highlighted the healthy 
conditions of the cells proliferated on the multiwell floor in direct contact with both types of 
microbeads. 
The data here reported confirm the biocompatibility of silver nanoparticles stabilized within 
the Chitlac matrix and the suitability of Chitlac-nAg for the preparation of bioactive 
polysaccharide-based biomaterials, in line with previous approaches by some of the authors 
(Marsich et al. 2013; Travan et al. 2009; Travan et al. 2012). The slight increase of 
cytotoxicity observed at 72 hours can be due to two different factors: i) the accumulation of 
silver in the culture medium, which was not changed during the test according to the 
standardized protocol; ii) the limited mimicking of the in vivo conditions in a cytotoxicity 
assay  on 2D-cultured cells. These hypotheses are supported by Stojkovska et al. (Stojkovska 
et al. 2014), who reported a higher cytotoxicity of silver nanoparticles on 2D cultures of 
chondrocytes with respect to the 3D environment of perfused bioreactors. Moreover, 
according to the standards for the determination of the cytotoxicity of materials (accordingly 
to the ISO 10993−5 standard(1999)), the values of LDH released by the cells in contact with 
nAg-MB are significantly lower than the threshold considered as cytotoxic (30% of LDH 
released over the total content). 
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3.6 Injectability studies 
As soon as the composite microbeads were characterized and their biological properties 
assessed, the material was employed for the preparation of an injectable system based on 
dried MB suspended in a suspending liquid medium. The latter was selected through a 
preliminary screening of polysaccharide solutions by evaluating the homogeneity and 
stability over time of the suspension resulting from the dispersion of the microbeads in the 
viscous polysaccharide solution. This screening study enabled to select alginate solution (4% 
w/V) with 30% w/w of microbeads as the best performing formulation, since this 
composition could be stored within syringes for ten days maintaining the particles 
homogeneously distributed within the alginate medium (Figure 9A). The choice of alginate as 
a dispersant agent is also supported by literature studies: for example, Alves Cardoso et al. 
(Alves et al. 2014) and Oliveira et al. (Oliveira et al. 2008) reported the use of alginate for 
the preparation of an injectable, osteoconductive material based on HAp or calcium 
phosphate. 
In order to assess the injectability of this formulation, the force required to extrude it through 
a syringe with a 2 mm nozzle diameter was tested by means of a universal testing machine. 
This diameter nozzle is in the typical range for cannulas used for bone cement injections 
(Tadier et al. 2014). The results of the mechanical tests are reported in Figure 9B (blue line).  
 
The data showed that it was possible to push the syringe plunger for the whole length of the 
syringe 
(50 mm) without stacking the particles or blocking the nozzle with an average compression 
load of 17 N (± 5 N), thus achieving a 100% extrusion of the paste. These values are in line 
with injectable materials developed by other authors (Perut et al. 2011; Sohrabi et al. 2013; 
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Sohrabi et al. 2014; Tadier et al. 2014) and highlight the capability of this bone filler to be 
injected in a surgical procedure.  
Another important feature of the formulation here proposed is that during the storage and the 
extrusion of the formulation, no phase-separation phenomena of the microbeads from the 
liquid phase was observed. Phase separation is a critical issue for the injectable fillers as it 
may negatively affect the homogeneity and the injectability of the materials (Tadier et al. 
2014). 
In order to evaluate the morphology of the particles in the dispersion medium, a SEM 
investigation has been performed after withdrawing the microbeads from the alginate solution 
(Figure 10): the images showed that the particles displayed a smoother surface than the native 
microbeads. This could be ascribed to the adsorption of some alginate from the solution onto 
the microbeads surface. 
In addition to the results obtained using alginate as dispersing agent, the possibility to add 
another polysaccharide to the solution has been explored with the aim to implement the 
bioactive properties of the injectable paste. To this end, hyaluronan has been selected as the 
additional solution component, given its healing capability and lubricating properties (Dicker 
et al. 2014). A high MW (1.5 106) HA sample was chosen (HA 150). A mixed 
alginate/HA150 solution was prepared in which the concentration of the two polysaccharides 
was 3% w/V  and 1% w/V, respectively, thus providing the same polymer mass concentration 
as in the HA-free case (4% w/V). Microbeads were added at the same content as in the pure 
alginate condition (30% w/w), also in this case obtaining a homogeneous dispersion that was 
tested in terms of injectability. The mechanical tests revealed that the presence of HA led to a 
considerable decrease of the force required for the extrusion of the injectable filler, with an 
average compression load of 2 N (± 1 N) required for the plunger to push the paste out of the 
  
This article is protected by copyright. All rights reserved. 
syringe (Figure 9B, magenta line). Moreover, as observed in the formulation with alginate 
4% w/V, phase-separation phenomena were not observed during the extrusion. 
 This finding suggests that the addition of HA to the alginate-microbeads paste is able to 
lubricate the particles during the extrusion through the syringe, while implementing the 
bioactive properties of the injectable biomaterial. 
 
4 Conclusions 
 
Microbeads based on hydroxyapatite, alginate, and Chitlac-nAg were developed and 
characterized for the preparation of injectable bone fillers. The dried microbeads displayed a 
rapid swelling in contact with simulated body fluids and maintained their integrity for more 
than 30 days. The evaluation of silver leakage from the microbeads showed that the 
antibacterial metal is slowly released in saline solution, with less than 6% of silver released 
after 1 week. Antibacterial tests in vitro proved that the microbeads displayed bactericidal 
effects toward S. aureus, P. aeruginosa and S. epidermidis and that they were also able to 
damage pre-formed bacterial biofilms. The microbeads did not exert any cytotoxic effect 
towards osteoblast-like cells. Upon suspension of the particles in alginate (or 
alginate/hyaluronic acid) solution, a homogenous and time-stable paste was obtained; 
mechanical tests enabled to quantify the extrusion forces from surgical syringes, pointing out 
the good injectability of the material. 
Overall, this novel antibacterial bone-filler appears as a promising material for the treatment 
of bone defects, in particular when possible infections could compromise the bone-healing 
process. Moreover, the components used for the preparation of the material (Chitlac and 
hydroxyapatite) could also provide the filler with osteoconductive properties. A detailed 
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characterization of the injectable paste, in terms of material properties and in vivo behavior 
will be the subject of a forthcoming study. 
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Figure 1. A) Schematic representation of the preparation of the microbeads: the 
alginate/HAp/Chitlac (with or without nAg) solution is dropped in a CaCl2 solution under the 
application of a voltage. B) Dimension distribution of MB and nAg-MB. On the right, microbeads 
aspect: C), MB, D) nAg-MB. 
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Figure 2. SEM micrographs of MB (A, B) and nAg-MB (C, D). E) Distribution of microbeads dimension: 
MB and  nAg-MB. 
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Figure 3. A) Diameter changes during the swelling experiment. On the right, microbeads aspect after 
12 days of experiment: B), MB, C) nAg-MB. 
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Figure 4. Silver released by the microbeads (nAg-MB) soaked in deionized water or in saline solution 
expressed as percentage of the total silver contained: (A) release at given solution shift; (B) 
cumulative release. Data were averaged on three independent experiments.  
  
  
This article is protected by copyright. All rights reserved. 
 
 
Figure 5. Growth inhibition assay of bacteria treated with microbeads (MB or nAg-MB), compared to 
the growth control (Ctrl). S. aureus (A), P. aeruginosa (B) were incubated for 4 hours, while S. 
epidermidis (C) were incubated for 24 h. Statistical differences were determined by means of 
Student’s t test. **P < 0.01; ***P < 0.001. 
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Figure 6. Effect of microbeads on biofilms of S. aureus (A) and P. aeruginosa (B) after 4 hours of 
contact with the materials (Green Biofilm Cell Stain assay). Ctrl: untreated biofilm; MB: biofilm 
treated with MB particles; nAg-MB: biofilm treated with nAg-MB particles. Statistical significance 
was evaluated by Kruskal-Wallis and by Mann–Whitney non-parametric tests. *P < 0.05; **P < 0.01; 
***P < 0.001.  
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Figure 7. Effect of microbeads on biofilms of S. aureus (A-C) and P. aeruginosa (E-G) after 4 hours of 
contact with the materials (Live/Dead assay). Control: untreated biofilm; MB: biofilm treated with 
MB particles; nAg-MB: biofilm treated with nAg-MB particles. For all images, green fluorescence 
(SYTO® 9) indicates live cells whereas red fluorescence (propidium iodide) refers to dead ones. 
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Figure 8. Evaluation of material cytotoxicity towards MG63 osteoblast-like cells. A) LDH assay after 
24 h and 72 h on cells in direct contact with the materials. Ctrl: adhesion control on multiwell, MB: 
cells in contact with MB particles, nAg-MB: cells in contact with nAg-MB particles PS: cells in contact 
with polystyrene membrane (negative control), PU/Zn: cells in contact with polyurethane/zinc 
membranes (positive control). Statistical differences were determined by means of Kruskal-Wallis 
and by Mann–Whitney non-parametric tests. *P < 0.05. B) Microscopic image of the cells after 72 
hours.  
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Figure 9. Injectability of MB microbeads dispersed in polysaccharide solutions. A) Image of the 
syringe employed to extrude the injectable pastes. B) Load-displacement (representative) curves 
recorded by compressing the plunger to extrude the paste out of the syringe. Blue line: 4% (w/V) 
alginate with 30% (w/w) MB microbeads. 
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Figure 10. SEM micrographs of alginate-coated MB microbeads (A, B) and of native MB microbeads 
(C, D). 
